Announcements Trials
Browse Landscape

Status

Completed 19Unknown 2Terminated 2Recruiting 2Not yet recruiting 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 138Neoplasms 134Lung Neoplasms 68Prostatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 58Colorectal Neoplasms 45Multiple Myeloma 37Pancreatic Neoplasms 34Melanoma 32Brain Neoplasms 31Head and Neck Neoplasms 30Neoplasm Metastasis 28Ovarian Neoplasms 27Liver Neoplasms 27Carcinoma, Hepatocellular 27Leukemia, Myeloid, Acute 25Colonic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Esophageal Neoplasms 20Carcinoma, Renal Cell 20Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 18Stomach Neoplasms 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Observational × Neuralgia × Clear all
NCT04287075 2024-03-26

Rethink Pain

Axogen Corporation

Terminated
8 enrolled

Neuralgia, Neuroma, Peripheral Nervous System Diseases, Peripheral Nerve Injuries, Chronic Pain

NCT01293851 2019-12-05

Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage

National Institutes of Health Clinical Center (CC)

Terminated
3 enrolled

Neoplasms, Neuralgia, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡